Tonix Pharmaceuticals Holding (TNXP) Interest & Investment Income (2023 - 2025)
Historic Interest & Investment Income for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $1.2 million.
- Tonix Pharmaceuticals Holding's Interest & Investment Income rose 673888.89% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 100757.58%. This contributed to the annual value of $1.7 million for FY2023, which is 806.19% down from last year.
- As of Q3 2025, Tonix Pharmaceuticals Holding's Interest & Investment Income stood at $1.2 million, which was up 673888.89% from $943000.0 recorded in Q2 2025.
- In the past 5 years, Tonix Pharmaceuticals Holding's Interest & Investment Income ranged from a high of $1.2 million in Q3 2025 and a low of $1000.0 during Q2 2024
- In the last 3 years, Tonix Pharmaceuticals Holding's Interest & Investment Income had a median value of $95000.0 in 2023 and averaged $395333.3.
- Per our database at Business Quant, Tonix Pharmaceuticals Holding's Interest & Investment Income tumbled by 8953.49% in 2024 and then surged by 9420000.0% in 2025.
- Tonix Pharmaceuticals Holding's Interest & Investment Income (Quarter) stood at $7000.0 in 2023, then surged by 157.14% to $18000.0 in 2024, then skyrocketed by 6738.89% to $1.2 million in 2025.
- Its Interest & Investment Income was $1.2 million in Q3 2025, compared to $943000.0 in Q2 2025 and $18000.0 in Q3 2024.